Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens
- PMID: 31672891
- PMCID: PMC8590458
- DOI: 10.1126/science.aay6485
Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens
Abstract
Measles virus is directly responsible for more than 100,000 deaths yearly. Epidemiological studies have associated measles with increased morbidity and mortality for years after infection, but the reasons why are poorly understood. Measles virus infects immune cells, causing acute immune suppression. To identify and quantify long-term effects of measles on the immune system, we used VirScan, an assay that tracks antibodies to thousands of pathogen epitopes in blood. We studied 77 unvaccinated children before and 2 months after natural measles virus infection. Measles caused elimination of 11 to 73% of the antibody repertoire across individuals. Recovery of antibodies was detected after natural reexposure to pathogens. Notably, these immune system effects were not observed in infants vaccinated against MMR (measles, mumps, and rubella), but were confirmed in measles-infected macaques. The reduction in humoral immune memory after measles infection generates potential vulnerability to future infections, underscoring the need for widespread vaccination.
Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
Conflict of interest statement
Figures
Comment in
-
Game of clones: How measles remodels the B cell landscape.Sci Immunol. 2019 Nov 1;4(41):eaaz4195. doi: 10.1126/sciimmunol.aaz4195. Sci Immunol. 2019. PMID: 31672863 Free PMC article. Review.
-
Measles increases the risk of other infections.Nat Rev Microbiol. 2020 Jan;18(1):2. doi: 10.1038/s41579-019-0301-7. Nat Rev Microbiol. 2020. PMID: 31728062 No abstract available.
-
Measles infection leads to long-term immune suppression, not noted with MMR vaccine.J Pediatr. 2020 Mar;218:259-262. doi: 10.1016/j.jpeds.2019.12.049. J Pediatr. 2020. PMID: 32089182 No abstract available.
Similar articles
-
Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella.Vaccine. 2000 Jan 31;18(14):1382-92. doi: 10.1016/s0264-410x(99)00397-7. Vaccine. 2000. PMID: 10618536 Clinical Trial.
-
Assessment of immune status against measles, mumps, and rubella in young Kuwaitis: MMR vaccine efficacy.J Med Virol. 2020 Aug;92(8):963-970. doi: 10.1002/jmv.25665. Epub 2020 Feb 3. J Med Virol. 2020. PMID: 31919861
-
Similar Antibody Levels in 3-Year-Old Children Vaccinated Against Measles, Mumps, and Rubella at the Age of 12 Months or 18 Months.J Infect Dis. 2016 Jun 15;213(12):2005-13. doi: 10.1093/infdis/jiw058. Epub 2016 Feb 9. J Infect Dis. 2016. PMID: 26908733
-
Open randomized trial comparing the immunogenicity and safety of a new measles-mumps-rubella vaccine and a licensed vaccine in 12- to 24-month-old children.Pediatr Infect Dis J. 2005 Dec;24(12):1083-8. doi: 10.1097/01.inf.0000183746.92218.f9. Pediatr Infect Dis J. 2005. PMID: 16371870 Clinical Trial.
-
Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage.J Infect Dis. 2013 Jul;208(1):10-6. doi: 10.1093/infdis/jit143. Epub 2013 May 8. J Infect Dis. 2013. PMID: 23661802 Free PMC article.
Cited by
-
Antibody profiling and predictive modeling discriminate between Kaposi sarcoma and asymptomatic KSHV infection.PLoS Pathog. 2024 Feb 21;20(2):e1012023. doi: 10.1371/journal.ppat.1012023. eCollection 2024 Feb. PLoS Pathog. 2024. PMID: 38381773 Free PMC article.
-
Stable Levels of Antibodies Against Unrelated Toxoid Vaccines After COVID-19: COVID-19 Infection Does Not Affect Toxoid Vaccine Antibody Levels.Pathog Immun. 2024 Feb 7;8(2):74-87. doi: 10.20411/pai.v8i2.627. eCollection 2023. Pathog Immun. 2024. PMID: 38347963 Free PMC article.
-
New insights into the ontogeny, diversity, maturation and survival of long-lived plasma cells.Nat Rev Immunol. 2024 Feb 8. doi: 10.1038/s41577-024-00991-0. Online ahead of print. Nat Rev Immunol. 2024. PMID: 38332373 Review.
-
Therapeutic mitigation of measles-like immune amnesia and exacerbated disease after prior respiratory virus infections in ferrets.Nat Commun. 2024 Feb 8;15(1):1189. doi: 10.1038/s41467-024-45418-5. Nat Commun. 2024. PMID: 38331906 Free PMC article.
-
Two centuries of vaccination: historical and conceptual approach and future perspectives.Front Public Health. 2024 Jan 9;11:1326154. doi: 10.3389/fpubh.2023.1326154. eCollection 2023. Front Public Health. 2024. PMID: 38264254 Free PMC article. Review.
References
-
- World Health Organization, New measles surveillance data for 2019 (2019); www.who.int/immunization/newsroom/measles-data-2019/en/.
-
- Pirquet C, Dtsch. Med. Wochenschr 34, 1297–1300 (1908).
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
